Following a successful evaluation by Accreditation Canada, the McGill University Health Centre (MUHC) has yet another good reason to celebrate and to keep up the good work. The MUHC is a designated Level 1 Choosing Wisely Canada hospital since May 29, taking the first step in the recognition of its commitment towards reducing overuse of tests and treatments for the benefit of patients. It is the first hospital in Quebec – and one of the five in Canada – to receive Level 1 designation.
“This is a first step, but this is an important one,” says Dr. Carolyn Freeman, Chair of the MUHC Clinical pertinence coordinating committee (CPCC), which was created in March, 2018. “This is a milestone.”
Part of a global movement that was created in the United States five years ago, Choosing Wisely Canada (CWC) is the national voice for reducing unnecessary tests and treatments in health care. One of its important functions is to help clinicians and patients engage in conversations that lead to smart and effective care choices through the use of a list of “Things Clinicians and Patients Should Question.” These lists contain recommendations of tests, treatments, and procedures to be used less or stopped altogether since they are not backed by evidence and could potentially expose patients to harm. To date, over 300 recommendations have been published.
The MUHC started with five quick wins in Level 1, five basic but important recommendations regarding the use of certain tests.
“In fact, these were well implemented already,” says Dr. Freeman. “It was a matter of documenting it to get the designation.”
“The MUHC has a long-standing commitment to high-quality and high-value care, so we were excited when this opportunity presented itself,” says Dr. Emily G. McDonald, assistant professor of medicine and member of the CPCC executive committee. “Many of the quick wins are established practice in our institution. Receiving the CWC designation is a well-deserved recognition for the quality care that the MUHC provides.”
Achieving Level 2 implies implementing three additional recommendations, while Level 3 is granted to organizations who lead by reducing overuse and promoting culture change.
“We believe the MUHC has all that it takes to achieve Level 3, and we are aiming to get the designation this year,” says Dr. Sebastian Negrete, assistant professor, Department of family medicine and member of the CPCC. “The efforts are made, the committees are working, and the administration strongly supports the initiative.”